References
- Andersson S, Dillner L, Elfgren K, et al (2005). A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities. Acta Obstet Gynecol Scand, 84, 996-1000. https://doi.org/10.1111/j.0001-6349.2005.00702.x
- Andrae B, Smith P (1999). Clinical impact of quality assurance in an organized cervical screening program. Acta Obstet Gynecol Scand, 78, 429-35. https://doi.org/10.1080/j.1600-0412.1999.780516.x
- Arbyn M, Buntinx F, Van Ranst M, et al (2004). Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst, 96, 280-93. https://doi.org/10.1093/jnci/djh037
- Candiloro IL, Mikeska T, Dobrovic A (2011). Assessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation. Epigenetics, 6, 500-7. https://doi.org/10.4161/epi.6.4.14853
- Carreon JD, Sherman ME, Guillen D, et al (2007). CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol, 26, 441-6. https://doi.org/10.1097/pgp.0b013e31805152ab
- Dehn D, Torkko KC, Shroyer KR (2007). Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma. Cancer, 111, 1-14. https://doi.org/10.1002/cncr.22425
- Dimitrakopoulos L, Vorkas PA, Georgoulias V, Lianidou ES (2012). A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples. BMC Cancer, 12, 486. https://doi.org/10.1186/1471-2407-12-486
- Huang TH, Lai HC, Liu HW, et al (2010). Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer. Int J Gynecol Cancer, 20, 513-9. https://doi.org/10.1111/IGC.0b013e3181c7fe6e
- Lai HC, Lin YW, Huang TH, et al (2008). Identification of novel DNA methylation markers in cervical cancer. Int J Cancer, 123, 161-7. https://doi.org/10.1002/ijc.23519
- Naucler P, Ryd W, Tornberg S, et al (2009). Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening. J Natl Cancer Inst, 101, 88-99. https://doi.org/10.1093/jnci/djn444
- Nieh S, Chen SF, Chu TY, et al (2005). Is p16 (INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies. Gynecol Oncol, 97, 35-40. https://doi.org/10.1016/j.ygyno.2004.11.034
- Park JS (1996). The role of HPV DNA testing in cervical neoplasia. J Obstet Gynaecol Res, 22, 611-20. https://doi.org/10.1111/j.1447-0756.1996.tb01079.x
- Silverloo I, Andrae B, Wilander E (2009). Value of high-risk HPV-DNA testing in the triage of ASCUS. Acta Obstet Gynecol Scand, 88, 1006-10. https://doi.org/10.1080/00016340903160952
- Siriaunkgul S, Settakorn J, Sukpan K, et al (2014). Populationbased cervical cancer screening using high-risk HPV DNA test and liquid-based cytology in northern Thailand. Asian Pac J Cancer Prev, 15, 6837-42. https://doi.org/10.7314/APJCP.2014.15.16.6837
- Wang JL, Yang YZ, Dong WW, et al (2013). Application of human papillomavirus in screening for cervical cancer and precancerous lesions. Asian Pac J Cancer Prev, 14, 2979-82. https://doi.org/10.7314/APJCP.2013.14.5.2979
- Wentzensen N, Wilson LE, Wheeler CM, et al (2010). Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study. Cancer Res, 70, 8578-86. https://doi.org/10.1158/0008-5472.CAN-10-1188
- Wojdacz TK, Dobrovic A (2007). Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res, 35, 41. https://doi.org/10.1093/nar/gkm013
- Wojdacz TK (2012). Methylation-sensitive high-resolution melting in the context of legislative requirements for validation of analytical procedures for diagnostic applications. Expert Rev Mol Diagn, 12, 39-47. https://doi.org/10.1586/erm.11.88
- Wu W, Zhang J, Yang H, Shao Y, Yu B (2011). Examination of AKAP12 promoter methylation in skin cancer using methylation-sensitive high-resolution melting analysis. Clin Exp Dermatol, 36, 381-5. https://doi.org/10.1111/j.1365-2230.2010.03968.x
- Yarandi F, Shojaei H, Eftekhar Z, Izadi-Mood N (2009). Comparison of three management strategies for patients with atypical squamous cells of undetermined significance, after six months delay: a three-year experience in an Iranian university hospital. Aust N Z J Obstet Gynaecol, 49, 207-10. https://doi.org/10.1111/j.1479-828X.2009.00960.x
Cited by
- PAX1 Methylation as a Potential Biomarker to Predict the Progression of Cervical Intraepithelial Neoplasia vol.27, pp.7, 2017, https://doi.org/10.1097/IGC.0000000000001011
- ) gene methylation in cancer screening pp.23249269, 2019, https://doi.org/10.1002/mgg3.506